Hepatocellular carcinoma cost-effectiveness of therapy: Difference between revisions
Created page with "{{Hepatocellular carcinoma}} {{CMG}} ==Overview== ==References== {{Reflist|2}} Category:Disease Category:Types of cancer Category:Gastroenterology [[Category:..." |
m Bot: Removing from Primary care |
||
| (5 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Hepatocellular carcinoma}} | {{Hepatocellular carcinoma}} | ||
| Line 4: | Line 5: | ||
==Overview== | ==Overview== | ||
Hepatocellular carcinoma (HCC) most commonly appears in a patient with chronic viral hepatitis ([[hepatitis B]] or [[hepatitis C]], 20%) or with cirrhosis (about 80%). These patients commonly undergo surveillance with [[medical ultrasonography|ultrasound]] due to the cost-effectiveness. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Medicine]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Up-To-Date]] | |||
[[Category: | [[Category:Oncology]] | ||
[[Category:Hepatology]] | [[Category:Hepatology]] | ||
[[Category: | [[Category:Emergency medicine]] | ||
Latest revision as of 22:07, 29 July 2020
|
Hepatocellular carcinoma Microchapters |
|
Differentiating Hepatocellular carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatocellular carcinoma cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Hepatocellular carcinoma cost-effectiveness of therapy |
|
FDA on Hepatocellular carcinoma cost-effectiveness of therapy |
|
CDC on Hepatocellular carcinoma cost-effectiveness of therapy |
|
Hepatocellular carcinoma cost-effectiveness of therapy in the news |
|
Blogs on Hepatocellular carcinoma cost-effectiveness of therapy |
|
Risk calculators and risk factors for Hepatocellular carcinoma cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Hepatocellular carcinoma (HCC) most commonly appears in a patient with chronic viral hepatitis (hepatitis B or hepatitis C, 20%) or with cirrhosis (about 80%). These patients commonly undergo surveillance with ultrasound due to the cost-effectiveness.